The eyes and lids of mice (n=5 per experiment, in four independent sets of experiments, total of 20 per group, in NS, DS5, and DS10 groups and n=5 per experiment, in two independent sets of experiments in corneal scar and control groups) were excised, pooled, and incubated in 10ml of 5mgml−1 Dispase II (Roche Molecular Biochemicals, Indianapolis, IN) in a shaker at 37 ° C for 1 h, followed by neutralization with Hank ’s Buffered Salt Solution (Invitrogen-Gibco, Grand Island, NY) supplemented with 3% fetal bovine serum (Hyclone, Logan, UT). The bulbar and tarsal conjunctivae were scraped with cytology brushes under a dissecting microscope. Respective superficial CLNs were surgically excised, smashed in between two sterile frosted glass slides, and made into a single-cell suspension. Cell populations were individually collected, centrifuged at 2000r.p.m.×5min, filtered, and resuspended. Cells collected by this technique were used either for flow cytometry (desiccating stress experiment) or for ELISPOT (desiccating stress and corneal ulcer experiment).
>
Chemicals & Drugs
>
Amino Acid
>
Calnexin
Calnexin
Calnexin is a molecular chaperone protein that plays a critical role in the quality control of protein folding and assembly in the endoplasmic reticulum (ER).
It binds to newly synthesized glycoproteins, preventing their premature exit from the ER and promoting proper folding and maturation.
Calnexin also interacts with other ER-resident proteins, such as calreticulin and ERp57, to facilitate the formation of disulfide bonds and the proper assembly of multimeric protein complexes.
This chaperone activity is essential for the maintenance of cellular homeostasis and the prevention of protein misfolding diseases.
Reasearchers can leverage PubCompare.ai's AI-driven tools to optimize their Calnexin-related studies, easily locate the best research protocols, and streamline their workflow to accelerate discovery.
It binds to newly synthesized glycoproteins, preventing their premature exit from the ER and promoting proper folding and maturation.
Calnexin also interacts with other ER-resident proteins, such as calreticulin and ERp57, to facilitate the formation of disulfide bonds and the proper assembly of multimeric protein complexes.
This chaperone activity is essential for the maintenance of cellular homeostasis and the prevention of protein misfolding diseases.
Reasearchers can leverage PubCompare.ai's AI-driven tools to optimize their Calnexin-related studies, easily locate the best research protocols, and streamline their workflow to accelerate discovery.
Most cited protocols related to «Calnexin»
Calnexin
Cells
Conjunctiva
Corneal Ulcer
Cytological Techniques
dispase II
Enzyme-Linked Immunospot Assay
Eye
Fetal Bovine Serum
Flow Cytometry
Medulla Oblongata
Microscopy
Mus
Operative Surgical Procedures
Population Group
Sodium Chloride
Sterility, Reproductive
Samples were fixed, paraffin embedded, sectioned, and stained with hematoxylin/eosin for histological evaluation as described [57 (link)]. Tissue sections were subject to immunological staining with avidin:biotinylated enzyme complex as described [18 (link),58 (link)]. Proteins were extracted from TS cells using M-PER reagent (PIERCE) with the addition of protease inhibitor cocktail (Sigma-Aldrich), 1 mM sodium molybdate, 1 mM sodium vanadate, and 10 mM N-ethylmaleimide, or SDS lysis buffer (2% SDS, 10% glycerol, and 50 mM Tris, pH 6.8). Protein extracts were subject to immunoblotting as described [54 (link)]. Bound primary antibodies were detected with horseradish peroxidase-conjugated secondary antibodies (Vector Lab), followed by ECL-mediated visualization (GE HealthCare) and autoradiography. Mouse monoclonal antibodies anti-actin (Thermo Fisher; 1:1,000), anti-BrdU (Thermo Fisher; 1:300), anti-Cdx2 (BioGenex; 1:1), anti-MDM2 (Santa Cruz; 1:100), and anti-SUMO-1 (Zymed; 1:2,000); rabbit polyclonal antibodies anti-calnexin (Stressgene; 1:2,000), anti-cyclin D1 (Neomarker; 1:100), anti-Ki67 (Neomarker; 1:400), anti-laminin (Sigma-Aldrich; 1:25), anti-Myc tag (CalBioChem; 1:400), anti-Oct4 (Santa Cruz; 1:200), anti-p53 (Santa Cruz; 1:50), and anti-p450scc (Chemicon; 1:200); and goat polyclonal antibody anti-lamin B (Santa Cruz; 1:100) were used as primary antibodies. BrdU incorporation analysis was performed by intraperitoneal injection of BrdU (250 μg/g of body weight) into pregnant females for 1 h. Placentas were recovered, fixed, embedded, sectioned, and subject to immunostaining as described [18 (link),57 (link)].
Full text: Click here
Actins
Antibodies
Autoradiography
Avidin
Body Weight
Bromodeoxyuridine
Buffers
Calnexin
Cloning Vectors
Cyclin D1
Eosin
Ethylmaleimide
Glycerin
Goat
Horseradish Peroxidase
immunoglobulin B
Immunoglobulins
Injections, Intraperitoneal
Laminin
Lamins
Lamin Type B
MDM2 protein, human
Monoclonal Antibodies
Multienzyme Complexes
Mus
Paraffin
Placenta
POU5F1 protein, human
Pregnant Women
Protease Inhibitors
Proteins
Rabbits
sodium molybdate(VI)
Sodium Vanadate
SUMO1 protein, human
Tissues
Tromethamine
Cell culture media were from GIBCO BRL. TOPRO-3 and phalloidin-Alexa 568 (Molecular Probes, Inc.) were used to label nuclei and actin. MDC was from Sigma-Aldrich. γ-Secretase inhibitors were from Calbiochem (X or L685,458), Elan (DAPT), and AstraZeneca (Compound C).
Polyclonal anti-PS1-NTF (B19.2), -CTF (B32.1) and -TLN (B36.1) have been described previously (Annaert et al., 2001 (link)). B63.1 and B59.1 were generated using a synthetic peptide mimicking the final 16 and 18 amino acids of APP and nicastrin, respectively, coupled to KLH (Pierce Chemical Co.). Mab 9C3 against nicastrin was produced by immunizing the same peptide in balb/c mice followed by generation of a hybridoma cell line according to established procedures. We acknowledge the antibody gifts of anti-calnexin (A. Helenius, ETH Zurich, Zurich, Switzerland), anti-ergic-53 (J. Saraste, University of Bergen, Bergen, Norway) -LC3 (T. Yoshimori, National Institute of Genetics, Shizuoka-ken, Japan), -Apg12 (N. Mizushima, National Institute for Basic Biology, Okazaki, Japan), PIP2 (G. Hammond, Cancer Research Institute, London, UK), -LBPA (J. Gruenberg, University of Geneva, Geneva, Switzerland), and -APP COOH terminus (c 1/6.1; P. Mathews, Nathan Kline Institute, Orangeburg, NY). Mabs to Lamp-2 (Abl-93) were obtained from Developmental Studies Hybridoma Bank (Iowa City, Iowa); anti-synaptophysin (cl.7.2) and anti-PS1-CTF (mAb 5.2) were from R. Jahn (MPI-Göttingen, Göttingen, Germany) and B. Cordell (Scios Inc., Sunnyvale, CA). mAbs to GM130 and EEA1 were from BD Biosciences, the transferrin receptor from Zymed Laboratories, β-COP from Sigma-Aldrich, and BIP from StressGen Biotechnologies.
Polyclonal anti-PS1-NTF (B19.2), -CTF (B32.1) and -TLN (B36.1) have been described previously (Annaert et al., 2001 (link)). B63.1 and B59.1 were generated using a synthetic peptide mimicking the final 16 and 18 amino acids of APP and nicastrin, respectively, coupled to KLH (Pierce Chemical Co.). Mab 9C3 against nicastrin was produced by immunizing the same peptide in balb/c mice followed by generation of a hybridoma cell line according to established procedures. We acknowledge the antibody gifts of anti-calnexin (A. Helenius, ETH Zurich, Zurich, Switzerland), anti-ergic-53 (J. Saraste, University of Bergen, Bergen, Norway) -LC3 (T. Yoshimori, National Institute of Genetics, Shizuoka-ken, Japan), -Apg12 (N. Mizushima, National Institute for Basic Biology, Okazaki, Japan), PIP2 (G. Hammond, Cancer Research Institute, London, UK), -LBPA (J. Gruenberg, University of Geneva, Geneva, Switzerland), and -APP COOH terminus (c 1/6.1; P. Mathews, Nathan Kline Institute, Orangeburg, NY). Mabs to Lamp-2 (Abl-93) were obtained from Developmental Studies Hybridoma Bank (Iowa City, Iowa); anti-synaptophysin (cl.7.2) and anti-PS1-CTF (mAb 5.2) were from R. Jahn (MPI-Göttingen, Göttingen, Germany) and B. Cordell (Scios Inc., Sunnyvale, CA). mAbs to GM130 and EEA1 were from BD Biosciences, the transferrin receptor from Zymed Laboratories, β-COP from Sigma-Aldrich, and BIP from StressGen Biotechnologies.
1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol
2-amino-5-phosphopentanoic acid
Actins
alexa 568
anti-synaptophysin
Antibodies, Anti-Idiotypic
Calnexin
Cell Culture Techniques
Cell Lines
Cell Nucleus
Cells
Culture Media
Gifts
Hybridomas
inhibitors
LAMP2 protein, human
Malignant Neoplasms
Mice, Inbred BALB C
Molecular Probes
Monoclonal Antibodies
Peptides
Phalloidine
Secretase
Transferrin Receptor
For qRT-PCR, the rib cages from 5-day-old mice (wild type (wt) and mutant (m/m)) were dissected and treated with collagenase (type 1A, 2 mg/ml) for 1 h at 37°C in Dulbecco’s modified Eagle’s medium (DMEM). The costal cartilage was dissected from individual ribs, and the perichondrium layer was removed. The cartilage was digested a second time with collagenase for 3 h to remove the collagen matrix and release the chondrocytes. The chondrocytes were passed through a cell strainer (70 μm) and washed with DMEM containing 10% FBS and following centrifugation washed again with PBS. The cell pellet was resuspended in 500 μl TriZol (Invitrogen), and total RNA was isolated according to the manufacturer’s instructions. First-strand cDNA was synthesised using random hexamer primers (Superscript III, Invitrogen), and qPCR was performed using the SYBR® green PCR protocol. Primer sequences were: BiP: 5′-ggcaccttcgatgtgtctcttc-3′ and rev: 5′-tccatgacccgctgatcaa-3′; Grp94: 5′-taagctgtatgtacgccgcgt-3′ and rev: 5′-ggagatcatcggaatccacaac-3′; Calnexin: 5′-tga ttt cct ctc cct ccc ctt-3′ and rev: 5′-cac tgg aac ctg ttg atg gtg a-3′; Calreticulin: 5′-gct acg tga agc tgt ttc cga-3′ and rev: 5′-aca tga acc ttc ttg gtg cca g-3’; Erp72: 5′-agt atg agc cca ggt tcc acg t-3′ and rev: 5′-aga agt ctt acg atg gcc cac c-3′. Each experiment included ‘no template’ controls, was run in duplicate and had an 18S RNA control. Each independent experiment was repeated three times, and the results were analysed by independent-samples t test.
For Western blot analysis, chondrocytes were isolated as above, but aliquots of 2 × 105 chondrocytes were prepared and resuspended in 5× sodium dodecyl sulphate (SDS) loading buffer containing DTT. These protein aliquots were separated by 4–12% SDS-polyacrylamide gel electrophoresis (PAGE; Invitrogen) then transferred to nitrocellulose membranes for Western blot analysis. Ponceau staining was used to confirm equal loading of total protein isolates.
Antibodies to key chaperones associated with the unfolded protein response were used at a dilution of either 1:500 (BiP, Grp94, Erp72 and PDI; all from Santa Cruz) or 1:100 (ATF-6 from Imgenex and Bcl-2 from Abcam).
For Western blot analysis, chondrocytes were isolated as above, but aliquots of 2 × 105 chondrocytes were prepared and resuspended in 5× sodium dodecyl sulphate (SDS) loading buffer containing DTT. These protein aliquots were separated by 4–12% SDS-polyacrylamide gel electrophoresis (PAGE; Invitrogen) then transferred to nitrocellulose membranes for Western blot analysis. Ponceau staining was used to confirm equal loading of total protein isolates.
Antibodies to key chaperones associated with the unfolded protein response were used at a dilution of either 1:500 (BiP, Grp94, Erp72 and PDI; all from Santa Cruz) or 1:100 (ATF-6 from Imgenex and Bcl-2 from Abcam).
Antibodies
BCL2 protein, human
Buffers
Calnexin
Calreticulin
Cartilage
Cells
Centrifugation
Chondrocyte
Collagen
Collagenase
Costal Cartilage
DNA, Complementary
Eagle
endoplasmic reticulum glycoprotein p72
GRP94
Molecular Chaperones
Mus
Nitrocellulose
Oligonucleotide Primers
Proteins
Rib Cage
Ribs
RNA, Ribosomal, 18S
SDS-PAGE
Sulfate, Sodium Dodecyl
SYBR Green I
Technique, Dilution
Tissue, Membrane
trizol
Unfolded Protein Response
Western Blot
Serological reagents used were: Anti-IIGP1 165 rabbit antiserum [35 (link)], anti-IIGP1 10E7, and 10D7 mouse monoclonal antibodies (mAb), anti-IGTP I68120 mAb (BD Transduction Laboratories, Lexington, Kentucky, United States), anti-TGTP1 A20 goat antiserum (Santa Cruz Biotechnology, Santa Cruz, California, United States), anti-LRG-47 A19 goat antiserum (Santa Cruz), anti-GTPI H53 rabbit antiserum raised against the N-terminal peptide MEEAVESPEVKEFEY, anti-IRG-47 2078 rabbit antiserum raised against the peptides CKTPYQHPKYPKVIF, and CDAKHLLRKIETVNVA, anti-T. gondii rabbit antiserum (BioGenex, San Ramon, California, United States), anti-LAMP1 1D4B rat mAb (University of Iowa, Iowa City, Iowa, United States), anti-GRA7 5–241–178 mouse mAb (gift from R. Ziemann, Abbott Laboratories, Abbot Park, Illinois, United States) [41 (link)], anti-ROP2/3/4 T24A7 mouse mAb (gift of J. Dubremetz, Montpellier, France) [59 (link)], anti-ctag1 2600 rabbit antiserum raised against the peptide CLKLGRLERPHRD, anti-ERP60 rabbit antiserum (gift from T. Wileman, BBSRC, Pirbright, United Kingdom), SPA-265 anti-calnexin rabbit antiserum (Stressgene), anti-PDI mAb (BD Transduction Laboratory), anti-Gm130 mAB (BD Transduction Laboratory), goat anti-mouse Alexa 546/488, goat anti-rabbit Alexa 546/488, donkey anti-goat Alexa 546/488, donkey anti-mouse Alexa 488, donkey anti-rabbit Alexa 488, donkey anti-rat Alexa 488, goat anti-rabbit Alexa 680 (Molecular Probes, Eugene, Oregon, United States).
Full text: Click here
Anti-Antibodies
Calnexin
Calreticulin
Equus asinus
Goat
Immune Sera
lysosomal-associated membrane protein 1, human
Mice, House
Molecular Probes
Peptides
Rabbits
Thomsen-Friedenreich antibodies
Most recents protocols related to «Calnexin»
Mouse monoclonal anti ACTIN, Sigma-Aldrich, A5441; Mouse monoclonal anti c-myc, Sigma-Aldrich, M4439; Rabbit polyclonal anti Calnexin, Enzo, ADI-SPA-865-F; Mouse monoclonal anti CYTC, BD Bioscience, 556433; Rabbit DyLight 680, Thermo Fisher Scientific, 35569; Mouse DyLight 680 Thermo Fisher Scientific, 35519; Mouse DyLight 800 Thermo Fisher Scientific, 35521; Rabbit DyLight 800 Thermo Fisher Scientific, 35571; Mouse monoclonal anti eIF2α, Cell Signaling, 2103S; Rabbit polyclonal anti-E-Syt1, Sigma-Aldrich, HPA016858; Rabbit polyclonal anti-GFP, Cell Signaling, 2555S; Mouse monoclonal anti-GFP,Life technologies, A11122; HRP Mouse Bioké, Cell Signaling, 7076; HRP Rabbit Bioké, Cell Signaling, 7074; Mouse monoclonal anti IP3R3, BD Bioscience, 610312; Rabbit polyclonal anti-PERK, Cell signaling, 3192S; Rabbit polyclonal anti PERK, Cell signaling, 5683S; Rabbit monoclonal anti Phospho-eIF2α (Ser51), Cell signaling, 3597S; Rabbit polyclonal anti PDI Genetex, GTX30716; Mouse monoclonal anti PSD, Santa Cruz, sc-390070; Rabbit polyclonal anti, PSS1 (B-5), Santa Cruz, sc-515376; Rabbit polyclonal anti PSS2, Sigma-Aldrich, SAB1303408; Rabbit polyclonal VDAC1, Cell Signaling, 4866S; Rabbit polyclonal VDAC1, Abcam, ab15895; Veriblot antibody Abcam, ab131366.
The reagents used were: Antimycin A, Sigma-Aldrich, A8674; Calcium Chloride dihydrate, Sigma-Aldrich, C3881; CHAPS hydrate, Sigma-Aldrich, C3023; Conjugated GFP antibody beads, Laboratory of Chris Ulens; D-Galactose, Sigma-Aldrich, G0750; D-glucose, Sigma-Aldrich, G7021-1KG; DAPI, Thermo Fisher Scientific, 62248; Dulbecco’s Modified Eagle’s Medium - high glucose, Sigma-Aldrich, D0422; EGTA, AppliChem, A0878; FCCP, Sigma-Aldrich, C2920; Gibco DMEM/F-12, Thermo Fisher Scientific, 11320074; Glucose, Agilent Seahorse, 103577; Glutamine, Sigma-Aldrich, G7513; Glutamine, Agilent Seahorse, 103579; GSK PERK Inhibitor, Toronto Research Company, G797800; Hygromycin B, Invivogen, ant-hg-1; Lipofectamine 2000 Transfection Reagent, Thermo Fisher Scientific, 11668019; MitoTracker FarRed, Thermo Fisher Scientific, M22426; NBD-PS, Avanti Polar Lipids, 810194C; SE Cell Line 4D-Nucleofector X Kit L, V4XC-1024; Oligomycin, Sigma-Aldrich, 75351; Penicillin and streptomycin, Sigma-Aldrich, P0781; Percoll, Sigma-Aldrich, P1644; Pierce ECL Western Blotting Substrate, Thermo Fisher Scientific, 32106X4; Pierce Protein A/G Magnetic Beads, Thermo Fisher Scientific, 88802; Pierce Protease Inhibitor Tablets, EDTA-free, Thermo Fisher Scientific, 88266; Potassium Chloride, Janssen Chimica, 7447407; Protease inhibitor, Thermo Fisher Scientific, A32953; Puromycin, Thermo Fisher Scientific, A11138-03; Protein A/G PLUS-Agarose, Santa Cruz, sc-2003; XF DMEM pH7 7.4, Agilent Seahorse, 103575; Sodium Chloride, Sigma-Aldrich, A0431796; Sodium Pyruvate Solution, Agilent Seahorse, 103578; Sucrose, Acros, A0333146; Thapsigargin, Enzo Life Sciences, BML-PE180; TransIT-X2 Dynamic Delivery System, Mirus Bio, MIR 6000; Tris base, Sigma-Aldrich, 77861; Triton, Sigma-Aldrich, T9234; Tween, Sigma Aldrich, P4780.
The reagents used were: Antimycin A, Sigma-Aldrich, A8674; Calcium Chloride dihydrate, Sigma-Aldrich, C3881; CHAPS hydrate, Sigma-Aldrich, C3023; Conjugated GFP antibody beads, Laboratory of Chris Ulens; D-Galactose, Sigma-Aldrich, G0750; D-glucose, Sigma-Aldrich, G7021-1KG; DAPI, Thermo Fisher Scientific, 62248; Dulbecco’s Modified Eagle’s Medium - high glucose, Sigma-Aldrich, D0422; EGTA, AppliChem, A0878; FCCP, Sigma-Aldrich, C2920; Gibco DMEM/F-12, Thermo Fisher Scientific, 11320074; Glucose, Agilent Seahorse, 103577; Glutamine, Sigma-Aldrich, G7513; Glutamine, Agilent Seahorse, 103579; GSK PERK Inhibitor, Toronto Research Company, G797800; Hygromycin B, Invivogen, ant-hg-1; Lipofectamine 2000 Transfection Reagent, Thermo Fisher Scientific, 11668019; MitoTracker FarRed, Thermo Fisher Scientific, M22426; NBD-PS, Avanti Polar Lipids, 810194C; SE Cell Line 4D-Nucleofector X Kit L, V4XC-1024; Oligomycin, Sigma-Aldrich, 75351; Penicillin and streptomycin, Sigma-Aldrich, P0781; Percoll, Sigma-Aldrich, P1644; Pierce ECL Western Blotting Substrate, Thermo Fisher Scientific, 32106X4; Pierce Protein A/G Magnetic Beads, Thermo Fisher Scientific, 88802; Pierce Protease Inhibitor Tablets, EDTA-free, Thermo Fisher Scientific, 88266; Potassium Chloride, Janssen Chimica, 7447407; Protease inhibitor, Thermo Fisher Scientific, A32953; Puromycin, Thermo Fisher Scientific, A11138-03; Protein A/G PLUS-Agarose, Santa Cruz, sc-2003; XF DMEM pH7 7.4, Agilent Seahorse, 103575; Sodium Chloride, Sigma-Aldrich, A0431796; Sodium Pyruvate Solution, Agilent Seahorse, 103578; Sucrose, Acros, A0333146; Thapsigargin, Enzo Life Sciences, BML-PE180; TransIT-X2 Dynamic Delivery System, Mirus Bio, MIR 6000; Tris base, Sigma-Aldrich, 77861; Triton, Sigma-Aldrich, T9234; Tween, Sigma Aldrich, P4780.
Full text: Click here
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate
Actins
Antimycin A
Calcium Chloride Dihydrate
Calnexin
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
DAPI
Eagle
Edetic Acid
Egtazic Acid
G-substrate
Galactose
Glucose
Glutamine
Hygromycin B
Immunoglobulins
L Cells
Lipids
lipofectamine 2000
Mus
N-(7-nitro-2,1,3-benzoxadiazol-4-yl)phosphatidylserine
Obstetric Delivery
Oligomycins
Peeling Skin Syndrome
Peeling skin syndrome, acral type
Penicillins
Percoll
Potassium Chloride
Protease Inhibitors
Puromycin
Pyruvate
Rabbits
Seahorses
Sepharose
Sodium
Sodium Chloride
Staphylococcal Protein A
Streptomycin
Sucrose
SYT1 protein, human
Thapsigargin
Transfection
Tromethamine
Tweens
VDAC1 protein, human
Extracellular vesicle containing fractions were lysed in 1X RIPA. Protein concentrations were determined by microBCA protein assay (Thermo Fisher, 23235). Equivalent protein amounts (extracellular vesicles and proteins) were separated on 4–15% stain-free precast SDS-PAGE gradient gels (Bio-Rad 5678083) under nonreducing conditions and transferred onto PVDF membranes (Sigma Aldrich IPVH00005). After 1 h blocking (5% nonfat milk, Bio-Rad 170–6404) at room temperature (RT), membranes were incubated with antibodies against CD63 (1 : 1000, BD Biosciences 556019), CD81 (1 : 500, Santa Cruz Biotechnology sc23962), calnexin (1 : 2000, Abcam ab22595), GM130 (1 : 1000, Abcam, ab76154), albumin (1 : 1000, Abcam ab28405), AGO2 (1 : 500, Sigma-Aldrich SAB4200085), ApoB100 (1 : 1000, Academy Bio-Medical 20A-G1b), ApoA1 (1 : 1000, Academy Bio-Medical 11A-G2b), and ApoC1 (1 : 1000, Academy Bio-Medical 31A-G1b) overnight at 4°C. Membranes were washed three times for 8 min in PBST with shaking, then incubated with HRP-conjugated secondary mouse antirabbit IgG or mouse IgG kappa binding protein antibodies (1 : 10 000, Santa Cruz Biotechnology sc-2357 and sc-516102) at RT for 1 h. After a PBST wash, membranes were incubated with SuperSignal West Pico PLUS chemiluminescent substrate (Thermo Fisher 34580) and visualized by iBright (Thermo Fisher, Waltham, Massachusetts, USA).
Albumins
Antibodies
APOA1 protein, human
Apolipoprotein B-100
apolipoprotein C-I, human
Binding Proteins
Biological Assay
Calnexin
EIF2C2 protein, human
Extracellular Vesicles
Gels
IGG-horseradish peroxidase
Mice, House
Milk, Cow's
polyvinylidene fluoride
Proteins
Radioimmunoprecipitation Assay
SDS-PAGE
Stains
Tissue, Membrane
For western blot (WB) analysis, equal amounts of EV pellet (30-50 ug, measured by Pierce BCA protein assay kit, CAT 23227) obtained from similar PPP volumes (250 ul) were combined with a 2xlysis buffer (RayBiotech) supplemented with 1% proteinase inhibitor and 1% phosphatase inhibitors (Sigma) containing β-mercaptoethanol (1:20, Biorad). Samples were loaded and separated on 4%–20% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad) and then transferred to Trans-Blot Turbo Mini 0.2 μm Nitrocellulose Transfer Packs (Bio-Rad). The membranes were stained with Ponceau S solution (P7170, sigma) to ensure that proteins transferred from the gel to the membrane (Supplementary Figure S3 ), were washed and immunoblotted with the appropriate antibodies against exosome markers. Mouse monoclonal anti human-CD63 (ab59479) and CD81 (ab79559) were both used in 1:1000 dilutions. Anti-rabbit, anti-human placental lactogen hormone (hPL) (ab137099; 1;25,000 dilution) and Calnexin (ab10286, 1;10,000 dilution) endoplasmic reticulum (ER) protein, not expected to be enriched in EVs, serve as negative control (all from Abcam, USA). Secondary antibodies (anti-mouse 115-035-146 and anti-rabbit 111-035-144, both in 1:5000 dilution) were purchased from Jackson ImmunoResearch (PA, USA). The blot was imaged and quantified by myECL™ Imager and analyzed by My Image Analysis Software (both from Thermo Fisher Scientific, Waltham, MA USA).
Full text: Click here
2-Mercaptoethanol
Antibodies
Biological Assay
Buffers
Calnexin
Endoplasmic Reticulum
Exosomes
Homo sapiens
Hormones
inhibitors
Mus
Nitrocellulose
Phosphoric Monoester Hydrolases
Placental Lactogen
ponceau S
Protease Inhibitors
Proteins
Rabbits
Technique, Dilution
Tissue, Membrane
Western Blot
Towbin transfer buffer was used to transfer 10 µg of EV protein separated by SDS-PAGE to a PVDF membrane (Merck Millipore, Germany) at 110 V for 70 min. followed by blockade with 5% skimmed milk powder (BD, USA) for 2.5 h. The membranes were incubated with rabbit polyclonal antibodies anti-CD63 (BBI Life Sciences, D160973; 1:1500, China), anti-CD9 (BBI Life Sciences, D164336; 1:1500, China), anti-TSG101 (ZEN BIO, 381,538; 1:1500, China), anti-calnexin (Abcam, ab75801; 1:1500, UK), and monoclonal antibodies anti-MUC4 (Abcam, ab150381; 1:1500, UK), anti-ACP5 (Abcam, ab191406; 1:1500, UK), mouse monoclonal antibodies anti-MEP1B (R&D Systems, MAB28951; 1:1500, USA) overnight at 4 ℃ followed by incubation with secondary antibody for 1.5 h at room temperature. An Ecl Kit (CWBIO, China) was used to visualize immunoreactive bands and was exposed to EC3 Imaging System (UVP).
Full text: Click here
ACP5 protein, human
Anti-Antibodies
Buffers
Calnexin
Immunoglobulins
Milk, Cow's
Monoclonal Antibodies
MUC4 protein, human
Mus
polyvinylidene fluoride
Powder
Proteins
Rabbits
SDS-PAGE
Tissue, Membrane
TSG101 protein, human
Mice were sacrificed and transcardially perfused with 4% paraformaldehyde (PFA) in cold phosphate-buffered saline (PBS). Mouse brains, superior cervical ganglions, and adrenal glands were collected, post-fixed in 4% PFA/PBS solution overnight, submerged in 30% sucrose in PBS for at least 72 h, and sectioned at 40 μm thickness using CM1950 cryostat (Leica)22 (link). Frozen sections were stained with antibodies specific to p150Glued (amino acid 3–202 at the N-terminus of p150Glued, BD Biosciences, #610474, 1:200, recognizing p150Glued but not p135+), p150Glued & p135+ (amino acid 1266–1278 at the C-terminus of p150Glued, Abcam, #ab11806, 1:500, recognizing both p150Glued and p135+), tyrosine hydroxylase (TH, Pel-Freez, #P40101-150, 1:2500; ImmunoStar, #22941, 1:500; Synaptic Systems, #213104, 1:500), dopamine transporter (DAT, Millipore, #MAB369, 1:500), vesicular monoamine transporter 2 (VMAT2, Synaptic Systems, #138302, 1:1000), glial fibrillary acidic protein (GFAP, Abcam, #ab7260, 1:1000), TAR DNA-binding protein 43 (TDP-43, Proteintech, #10782-2-AP, 1:500), α-synuclein (Santa Cruz, #sc-7011-R, 1:500; Santa Cruz, #sc-69977, 1:500), phosphorylated α-synuclein (Ser129) [p-α-synuclein (Ser129), Abcam, #ab51253, 1:500], neuronal nuclei (NeuN, Millipore, #ABN91, 1:500), synaptophysin (Millipore, #AB9272, 1:500), binding immunoglobulin protein (BiP, also referred to as GRP78, Abcam, #ab21685, 1:500), reticulon 3 (RTN3, Proteintech, #12055-2-AP, 1:500), 63 kDa cytoskeleton-linking membrane protein (CLIMP63, Proteintech, #16686-1-AP, 1:500), calnexin (Abcam, #ab22595, 1:500), protein disulfide isomerase (PDI, Proteintech, #11245-1-AP, 1:500), receptor binding cancer antigen expressed on SiSo cells (RCAS1, Cell Signaling Technology, #12290, 1:500), early endosome antigen 1 (EEA1, Cell Signaling Technology, #3288, 1:500), sequestosome 1 (SQSTM1, MBL, #PM066, 1:500), cathepsin D (R&D Systems, #AF1029, 1:500), ER-Golgi intermediate compartment 53 kDa protein (ERGIC53, Sigma-Aldrich, #E1031, 1:500), 130 kDa cis-Golgi matrix protein (GM130, BD Biosciences, #610822, 1:500), phosphorylated eukaryotic translation initiation factor 2α (Ser51) [p-eIF2α (Ser51), Abcam, #ab32157, 1:500], and phosphorylated inositol-requiring enzyme 1α (Ser724) [p-IRE1α (Ser724), Abcam, #ab48187, 1:500] as suggested by manufacturers. Alexa Fluor 488-, 546-, or 647-conjugated secondary antibody (Invitrogen, 1:500) was used to visualize the staining. Fluorescent images were captured using LSM 880 laser-scanning confocal microscope with Zen software (Zeiss) in conventional or Airyscan mode. As a high-resolution imaging modality, the Airyscan technology is reported to improve resolution 2-fold and signal-to-noise ratio 8-fold relative to the conventional confocal microscopy61 (link). The paired images in all the figures were collected at the same gain and offset settings. Post-collection processing was applied uniformly to all paired images. The images were presented as a single optic layer after acquisition in z-series stack scans at 1.0 μm intervals from individual fields or displayed as maximum-intensity projection or three-dimensional (3D) reconstruction to represent confocal stacks.
Full text: Click here
Adrenal Glands
alexa fluor 488
alpha-Synuclein
Amino Acids
Antibodies
Antigens
Binding Proteins
Brain
Calnexin
Cathepsin D
Cell Nucleus
Cells
Cold Temperature
Cytoskeleton
Dopamine Transporter
dynactin subunit 1, human
early endosome antigen 1
Enzymes
ERN1 protein, human
Eukaryotic Initiation Factors
Eye
Frozen Sections
Ganglia, Superior Cervical
Glial Fibrillary Acidic Protein
Glucose Regulated Protein 78 kDa
Golgi Apparatus
Golgin subfamily A member 2
Immunoglobulins
Inositol
Malignant Neoplasms
Membrane Proteins
Microscopy, Confocal
Mus
Neurons
paraform
Phosphates
Protein Disulfide-Isomerases
Proteins
protein TDP-43, human
Radionuclide Imaging
Reconstructive Surgical Procedures
Saline Solution
SQSTM1 protein, human
Sucrose
Synaptophysin
Tyrosine 3-Monooxygenase
Vesicular Monoamine Transporter 2
Top products related to «Calnexin»
Sourced in United Kingdom, United States, Germany, China
Calnexin is a chaperone protein found in the endoplasmic reticulum (ER) of eukaryotic cells. It is involved in the quality control of protein folding and assembly within the ER. Calnexin binds to and retains unfolded or misfolded glycoproteins, helping them to properly fold and assemble before they are transported out of the ER.
Sourced in United States, United Kingdom
Calnexin is a chaperone protein that assists in the folding and quality control of newly synthesized glycoproteins in the endoplasmic reticulum. It binds to and retains misfolded or incompletely assembled glycoproteins, allowing them to undergo additional folding or targeting for degradation.
Sourced in United States, Germany, China, United Kingdom, Morocco, Ireland, France, Italy, Japan, Canada, Spain, Switzerland, New Zealand, India, Hong Kong, Sao Tome and Principe, Sweden, Netherlands, Australia, Belgium, Austria
PVDF membranes are a type of laboratory equipment used for a variety of applications. They are made from polyvinylidene fluoride (PVDF), a durable and chemically resistant material. PVDF membranes are known for their high mechanical strength, thermal stability, and resistance to a wide range of chemicals. They are commonly used in various filtration, separation, and analysis processes in scientific and research settings.
Sourced in United Kingdom, United States, China
Ab22595 is a monoclonal antibody that targets the Histone H3 (tri methyl K9) protein. It is designed for use in various immunoassay applications.
Sourced in United States, United Kingdom
Anti-Calnexin is a protein-specific antibody that recognizes the calnexin protein. Calnexin is a membrane-bound chaperone protein that plays a role in the folding and quality control of newly synthesized glycoproteins in the endoplasmic reticulum.
Sourced in United States, Germany
Calnexin is a type I membrane protein that functions as a molecular chaperone in the endoplasmic reticulum (ER). It plays a key role in the quality control of newly synthesized glycoproteins, assisting in their proper folding and preventing the release of misfolded proteins. Calnexin interacts with monoglucosylated glycoproteins, retaining them in the ER until they achieve their native conformation.
Sourced in United States, United Kingdom, China, Japan, Germany
TSG101 is a protein involved in the endosomal-lysosomal pathway and functions in the sorting of ubiquitinated proteins into multivesicular bodies. It is a component of the ESCRT-I complex, which plays a role in the budding of vesicles from the limiting membrane of the endosome.
Sourced in United Kingdom, United States, China
Ab125011 is a laboratory product from Abcam. It is a recombinant protein.
Sourced in United States, United Kingdom
Anti-calnexin is a laboratory reagent used to detect the presence of the calnexin protein in cellular samples. Calnexin is a chaperone protein involved in the folding and quality control of newly synthesized glycoproteins within the endoplasmic reticulum. The anti-calnexin antibody can be used to identify and quantify calnexin levels in various cell and tissue types.
Sourced in United States, United Kingdom, Germany, China, Canada, Japan, Macao, Italy, Sao Tome and Principe, Israel, Spain, Denmark, France, Finland, Australia, Morocco, Ireland, Czechia, Sweden, Uruguay, Switzerland, Netherlands, Senegal
β-actin is a protein that is found in all eukaryotic cells and is involved in the structure and function of the cytoskeleton. It is a key component of the actin filaments that make up the cytoskeleton and plays a critical role in cell motility, cell division, and other cellular processes.
More about "Calnexin"
Calnexin is a critical molecular chaperone protein that plays a pivotal role in the quality control of protein folding and assembly within the endoplasmic reticulum (ER).
This ER-resident protein binds to newly synthesized glycoproteins, preventing their premature exit from the ER and promoting proper folding and maturation.
Calnexin also interacts with other key ER proteins, such as calreticulin and ERp57, to facilitate the formation of disulfide bonds and the proper assembly of multimeric protein complexes.
This chaperone activity is essential for maintaining cellular homeostasis and preventing protein misfolding diseases.
Researchers can leverage the powerful AI-driven tools provided by PubCompare.ai to optimize their Calnexin-related studies.
These tools can help identify the best research protocols from literature, preprints, and patents, streamlining the workflow and accelerating discovery.
By utilizing PubCompare.ai's platform, scientists can easily locate the most effective products and protocols for their Calnexin research, including PVDF membranes, anti-Calnexin antibodies (e.g., Ab22595, Ab125011), and even the use of the internal control protein β-actin.
Calnexin is closely associated with the protein TSG101, which plays a critical role in the endosomal sorting complex required for transport (ESCRT) pathway.
The interplay between Calnexin and TSG101 is an area of ongoing research, as it may provide insights into the cellular mechanisms involved in protein quality control and trafficking.
PubCompare.ai's AI-powered tools empower researchers to optimize their Calnexin studies, streamline their workflows, and accelerate the pace of discovery.
Experiance the power of AI-driven protocol optimization today and unlock new insights in your Calnexin-related research.
This ER-resident protein binds to newly synthesized glycoproteins, preventing their premature exit from the ER and promoting proper folding and maturation.
Calnexin also interacts with other key ER proteins, such as calreticulin and ERp57, to facilitate the formation of disulfide bonds and the proper assembly of multimeric protein complexes.
This chaperone activity is essential for maintaining cellular homeostasis and preventing protein misfolding diseases.
Researchers can leverage the powerful AI-driven tools provided by PubCompare.ai to optimize their Calnexin-related studies.
These tools can help identify the best research protocols from literature, preprints, and patents, streamlining the workflow and accelerating discovery.
By utilizing PubCompare.ai's platform, scientists can easily locate the most effective products and protocols for their Calnexin research, including PVDF membranes, anti-Calnexin antibodies (e.g., Ab22595, Ab125011), and even the use of the internal control protein β-actin.
Calnexin is closely associated with the protein TSG101, which plays a critical role in the endosomal sorting complex required for transport (ESCRT) pathway.
The interplay between Calnexin and TSG101 is an area of ongoing research, as it may provide insights into the cellular mechanisms involved in protein quality control and trafficking.
PubCompare.ai's AI-powered tools empower researchers to optimize their Calnexin studies, streamline their workflows, and accelerate the pace of discovery.
Experiance the power of AI-driven protocol optimization today and unlock new insights in your Calnexin-related research.